Tyris Therapeutics was founded by Columbus Venture Partners to transform DNA-based therapies with unique DNA format (oDNA™) and innovative Non-Viral delivery
Expanding the reach of gene therapies is our mission
Tyris objective is to provide the next generation of non-viral gene therapies for every patient, for any diseases whatever the size of the gene(s) involved, providing a safer and lifelong control of the disease through drug titration and redosing.
And transforming the life of patients is our driver
With that purpose in mind, our experienced team of talented scientists is passionate on discovering and developing the next generation of non-viral gene therapy treatments, to transform the life of patients suffering from rare and more prevalent diseases.